Issue

Vol. 35 No. 4 (2023): Vol 35 Issue 4, 2023

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Simultaneous Estimation of Repaglinide and Voglibose in Newly Approved Fixed-Dose Combination by using UFLC: Application to ICH Q14 Concept and Comparative Method Greenness Assessment

https://doi.org/10.14233/ajchem.2023.27579
S.S. Panda
Department of Pharmaceutical Analysis & Quality Assurance, Roland Institute of Pharmaceutical Sciences, Berhampur-760010, India
https://orcid.org/0000-0002-9138-5561
P.C. Rauta
Department of Pharmaceutical Analysis & Quality Assurance, Roland Institute of Pharmaceutical Sciences, Berhampur-760010, India
V.S. Pulusu
Department of Chemistry & Biochemistry, Ohio University, Athens, OH, USA
https://orcid.org/0000-0003-1801-6388
S. Sahu
Department of Pharmaceutical Chemistry, Dadhichi College of Pharmacy, Cuttack-754002, India
https://orcid.org/0009-0005-6528-9807
B.B. Dash
Department of Pharmaceutical Analysis, Anwarul Uloom College of Pharmacy, Hyderabad-500001, India
https://orcid.org/0009-0003-7493-7189

Corresponding Author(s) : S.S. Panda

sagarguddu2002@gmail.com

Asian Journal of Chemistry, Vol. 35 No. 4 (2023): Vol 35 Issue 4, 2023

Abstract

A validated liquid chromatographic method was developed to estimate repaglinide and voglibose present in a newly approved fixed dose combination. Critical method variables such as organic proportion, pH and flow of the mobile phase were identified. The identified variables were investigated using chemometrics and effect on analyte retention and resolution was studied. The optimized chromatographic condition utilized acetonitrile: 0.01 M KH2PO4 buffer pH 3.4 (using orthophosphoric acid) (79:21%, v/v) flowing at a flow rate of 1.2 mL/min. Diode array detection was carried out at 244 nm.The new analytical method was validated as per ICH regulations and found to be linear, accurate, precise and sensitive. Both drugs were recovered to the optimum (> 99%) level. Further, method greenness was compared by using multiple tools. This developed method based on ICH Q14 concept is scientifically sound and can be applied for quality control of both the anti-diabetic drugs in their combined formulation.

Keywords

Box-Behnken design Chemometrics Repaglinide Robustness Voglibose
Panda, S., Rauta, P., Pulusu, V., Sahu, S., & Dash, B. (2023). Simultaneous Estimation of Repaglinide and Voglibose in Newly Approved Fixed-Dose Combination by using UFLC: Application to ICH Q14 Concept and Comparative Method Greenness Assessment. Asian Journal of Chemistry, 35(4), 887–895. https://doi.org/10.14233/ajchem.2023.27579
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. S. Alam, M.K. Hasan, S. Neaz, N. Hussain, M.F. Hossain and T. Rahman, Diabetology, 2, 36 (2021); https://doi.org/10.3390/diabetology2020004
  2. J.A. Shin, J.H. Lee, S.Y. Lim, H.S. Ha, H.S. Kwon, Y.M. Park, W.C. Lee, M.I. Kang, H.W. Yim, K.H. Yoon and H.W. Son, J. Diabetes Investig., 4, 334 (2013); https://doi.org/10.1111/jdi.12075
  3. M. Asif, J. Educ. Health Promot., 3, 1 (2014); https://doi.org/10.4103/2277-9531.127541
  4. C.Y. Wang, D.L. Neil and P. Home, Diabetes Res. Clin. Pract., 143, 101 (2018); https://doi.org/10.1016/j.diabres.2018.06.007
  5. M.H. Moneva and S. Dagogo-Jack, Curr. Drug Targets, 3, 203 (2005).
  6. R. Miccoli, G. Penno and S. Del Prato, Diabetes Care, 34(Suppl. 2), S231 (2011); https://doi.org/10.2337/dc11-s235
  7. J.J. Marín-Peñalver, I. Martín-Timón, C. Sevillano-Collantes and F.J. Cañizo-Gómez, World J. Diabetes, 7, 354 (2016); https://doi.org/10.4239/wjd.v7.i17.354
  8. A. Cahn and W.T. Cefalu, Diabetes Care, 39(Suppl. 2), S137 (2016); https://doi.org/10.2337/dcS15-3007
  9. A. Chaudhury, C. Duvoor, V.S. Reddy Dendi, S. Kraleti, A. Chada, R. Ravilla, A. Marco, N.S. Shekhawat, M.T. Montales, K. Kuriakose, A. Sasapu, A. Beebe, N. Patil, C.K. Musham, G.P. Lohani and W. Mirza, Front. Endocrinol., 8, 1 (2017); https://doi.org/10.3389/fendo.2017.00006
  10. S. Mudaliar and R. Henry, Endocr. Pract., 5, 208 (1999); https://doi.org/10.4158/EP.5.4.208
  11. M.K. Moon, K.Y. Hur, S.H. Ko, S.O. Park, B.W. Lee, J.H. Kim, S.Y. Rhee, H.J. Kim, K.M. Choi and N.-H. Kim, Diabetes Metab. J., 41, 357 (2017); https://doi.org/10.4093/dmj.2017.41.5.357
  12. https://cdsco.gov.in/opencms/opencms/system/modules/ CDSCO.WEB /elements /download_file_division.jsp?num_id=NTQyMw==
  13. S.C. Sweetman, Martindale: The Complete Drug Reference, Pharmaceutical Press: London, p. 464 (2009).
  14. O.E. Johansen and K.I. Birkeland, Am. J. Cardiovasc. Drugs, 7, 319 (2007); https://doi.org/10.2165/00129784-200707050-00002
  15. L.J. Scott, Drugs, 72, 249 (2012); https://doi.org/10.2165/11207600-000000000-00000
  16. A.S. Benzaken, M.C.P. Oliveira, G.F.M. Pereira, S.P. Giozza, F.M.A. Souza, A.R.C. Cunha and R. Girade, Medicine, 97, 1 (2018); https://doi.org/10.1097/MD.0000000000010109
  17. P. Raskin, Diabetes Obes. Metab., 10, 1167 (2008); https://doi.org/10.1111/j.1463-1326.2008.00907.x
  18. S.C. Sweetman, Martindale: The Complete Drug Reference, Pharmaceutical Press: London, p. 464 (2009).
  19. A.S. Dabhi, N.R. Bhatt and M.J. Shah, J. Clin. Diagn. Res., 7, 3023 (2013); https://doi.org/10.7860/JCDR/2013/6373.3838
  20. H. Konya, T. Katsuno, T. Tsunoda, Y. Yano, M. Kamitani, M. Miuchi, T. Hamaguchi, J.I. Miyagawa and M. Namba, Diabetes Metab. Syndr. Obes., 6, 317 (2013); https://doi.org/10.2147/DMSO.S36046
  21. K. Kaku, Expert Opin. Pharmacother., 15, 1181 (2014); https://doi.org/10.1517/14656566.2014.918956
  22. S.H. Min, J.H. Yoon, S. Hahn and Y.M. Cho, J. Diabetes Investig., 9, 893 (2018); https://doi.org/10.1111/jdi.12754
  23. J.M. Patel, V. Kotadiya, N. Tiwari and P. Patani, J. Emerg. Technol. Innov. Res., 8, g92 (2021).
  24. M. Khusbu and P. Anjana, Int. J. All Res. Educ. Sci. Methods, 9, 1285 (2021).
  25. ICH Expert Working Group, ICH harmonized tripartite guideline-Analytical Procedure Development and Revision of Q2(R1): Q14. In Geneva: International Conference for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (2018).
  26. R. Deidda, S. Orlandini, P. Hubert and C. Hubert, J. Pharm. Biomed. Anal., 161, 110 (2018); https://doi.org/10.1016/j.jpba.2018.07.050
  27. ICH Expert Working Group, ICH Harmonized Tripartite Guideline-Quality Risk Management: Q9. In Geneva: International Conference for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (2005).
  28. https://www.usp.org/sites/default/files/usp/document/get-involved/stakeholder-forums/stimuli-articles-analytical-control-strategy-analytical-target-profile-2016-10-13.pdf
  29. M. Yabre, L. Ferey, I.T. Some and K. Gaudin, Molecules, 23, 1065 (2018); https://doi.org/10.3390/molecules23051065
  30. M. Alrobaian, S.S. Panda, W.H. Almalki, O. Afzal, I. Kazmi, M.A. Alossaimi, F.A. Al-Abbasi, H.A. Katouah, R.A. Rub, B.V.V.R. Kumar, M. Rahman and S. Beg, J. Chromatogr. Sci., 60, 559 (2022); https://doi.org/10.1093/chromsci/bmab094
  31. A. Galuszka, Z. Migaszewski and J. Namieœnik, Trends Analyt. Chem., 50, 78 (2013); https://doi.org/10.1016/j.trac.2013.04.010
  32. M. Tobiszewski, Anal. Methods, 8, 2993 (2016); https://doi.org/10.1039/C6AY00478D
  33. J. Plotka-Wasylka, Talanta, 181, 204 (2018); https://doi.org/10.1016/j.talanta.2018.01.013
  34. F. Pena-Pereira, W. Wojnowski and M. Tobiszewski, Anal. Chem., 92, 10076 (2020); https://doi.org/10.1021/acs.analchem.0c01887
  35. ICH Expert Working Group, ICH Harmonized Tripartite Guideline-Validation of Analytical Procedures Text and Methodology: Q2(R1). In Geneva: International Conference for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (2005).
  36. S.S. Panda, V.V.R.K. Bera, S. Beg and S.K. Sahu, J. Chromatogr. Sci., 53, 1193 (2015); https://doi.org/10.1093/chromsci/bmu228
  37. Y. Vander Heyden, M. Jimidar, E. Hund, N. Niemeijer, R. Peeters, J. Smeyers-Verbeke, D.L. Massart and J. Hoogmartens, J. Chromatogr. A, 845, 145 (1999); https://doi.org/10.1016/S0021-9673(99)00328-3
Read More
Author biographies is not available.
Download
AJC-35-4-13
Statistic
Read Counter : 0 Download : 0